Prenetics Global Limited (NASDAQ:PRE) Short Interest Up 22.1% in February

Prenetics Global Limited (NASDAQ:PREGet Free Report) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 39,800 shares, an increase of 22.1% from the January 31st total of 32,600 shares. Based on an average daily volume of 14,100 shares, the days-to-cover ratio is presently 2.8 days. Currently, 0.5% of the company’s stock are short sold.

Prenetics Global Stock Performance

NASDAQ PRE opened at $4.86 on Friday. The stock has a 50-day moving average of $5.47 and a 200 day moving average of $5.01. Prenetics Global has a one year low of $2.85 and a one year high of $7.84. The company has a market capitalization of $59.32 million, a price-to-earnings ratio of -1.22 and a beta of -0.31.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Prenetics Global stock. Quinn Opportunity Partners LLC acquired a new position in Prenetics Global Limited (NASDAQ:PREFree Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,339 shares of the company’s stock, valued at approximately $72,000. Quinn Opportunity Partners LLC owned approximately 0.10% of Prenetics Global at the end of the most recent reporting period. Institutional investors and hedge funds own 25.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $9.00 target price on shares of Prenetics Global in a research note on Thursday, January 16th.

View Our Latest Analysis on Prenetics Global

About Prenetics Global

(Get Free Report)

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.

Featured Articles

Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.